Usefulness of high doses of glucocorticoids and hyperbaric oxygen therapy in sudden sensorineural hearing loss treatment

Otology and Neurotology

Volumn 25, Issue 6, 2004, Pages 916-923

  Narozny, Waldemar ^a   Sicko, Zdzisław ^a   Przewozny, Tomasz ^a   Stankiewicz, Czeslaw ^a   Kot, Jacek ^a   Kuczkowski, Jerzy ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Glucocorticoids; Hyperbaric oxygen therapy; Inner ear; Sudden sensorineural hearing loss; Treatment

Indexed keywords

BETAHISTINE; BETSERC; CINNARIZINE; COCARBOXYLASE; DEXTRAN 40; GLUCOCORTICOID; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; PENTOXIFYLLINE; PIRACETAM; PREDNISONE; PROCAINE; PYRIDOXINE; THIAMINE; VINPOCETINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; FREQUENCY ANALYZER; HEARING; HUMAN; HYPERBARIC OXYGEN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OXYGEN TENSION; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; CASE-CONTROL STUDIES; COCHLEA; FEMALE; GLUCOCORTICOIDS; HEARING LOSS, SUDDEN; HUMANS; HYPERBARIC OXYGENATION; MALE; MIDDLE AGED; OXYGEN; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 8544261158     PISSN: 15317129     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129492-200411000-00010     Document Type: Article

References (60)

1. Alexiou C, Arnold W, Fauser C, et al. Sudden sensorineural hearing loss: does application of glucocorticoid make sense? Otolaryngol Head Neck Surg 2001;127:253-8.
2. Stokroos RJ, Albers FWJ. The etiology of idiopathic sudden sensorineural hearing loss: a review of the literature. Acta Otorhinolaryngol Belg 1996;50:69-76.
3. Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977;86:463-80.
4. Wilson WR, Gulya AJ. Sudden sensorineural hearing loss. In Cummings CW, ed. Otolaryngology-Head and Neck Surgery. St. Louis: Mosby, 1993:3103-12.
5. Desloovere C, Germoupre P. Sudden sensorineural deafness: treatment with hyperbaric oxygen therapy after failure often day course of " classical" drug therapy. In Proceedings of the 23rd EUBS Congress. Bled. Slovenia:European Underwater and Baromedical Society, 1997:198-202.
6. Jain KK. Textbook of Hyperbaric Medicine. 3rd ed. Göttingen: Horgrefe & Huber Publishers, 1999.
7. Lenarz T. Evaluierungskriterien für Therapiemethoden bei tinnitus. In Proceedings of the IVth International Tinntus Seminar. Bordeaux, France, 1991.
8. Welslau W, Almeling M, Lammerding A, et al. How many HBO treatment are necessary for the therapy of sudden deafness and acute tinnitus? In Proceedings of the 23rd EUBS Congress. Bled, Slovenia: European Underwater and Baromedical Society, 1997:203-9.
9. Lamm C, Walliser U, Schumann K, et al. Sauerstoffpartialdruck-Mesungen in der Perilymphe der Scala tympani unter normo- und hyperbaren Bedingungen. HNO 1988;36:363-6.
10. Schumann K, Fischer B. Zur Behandlung von Innenohrenkrankungen: Erfahrungen mit der hyperbaren Sauerstofftherapie. Nat Med 1992;7:366-85.
11. Lamm K, Lamm C, Lamm H, et al. Simultane Sauerstoffpartial-druck- Bestimungen in der Scala tympani. Elektrokochleographie und Blutdruck-Messungen unter Lärmbelastungen bei Meerschweinchen. HNO 1988;36:367-72.
12. Thorne PR, Nuttall AL. Alterations in oxygenation of cochlea endolymph during loud sound exposure. Acta Otolaryngol Stockh 1989;107:71-9.
13. Sliwinska-Kowalska M, Rzadzinska A, Jedlinska U. et al. Hair cell regeneration in the chick basilar papilla after exposure to wideband noise: evidence for ganglion cell involvement. Hear Res 2000;148:197-212.
14. Theopold HM. Das akustische Trauma in Tierexperiment. Morphologische Veränderungen der Meerschweinchen-Cochlea im Knalltrauma. Laryngol Rhinol Otol 1978;57:706-16.
15. Stokroos RJ, Albers FWJ. Therapy of idiopathic sudden sensorineural hearing loss: a review of the literature. Acta Otorhinolaryngol Belg 1996;50:77-84.
16. Lamm K, Lamm H, Arnold W. Effect of hyperbaric oxygen therapy in comparison to conventional or placebo therapy or no treatment in idiopathic sudden hearing loss, acoustic trauma, noise-induced hearing loss and tinnitus: a literature survey. Adv Otorhinolaryngol 1998;54:86-99.
17. D'Aldin C, Cherny L. Dancer A. Medical treatments of the acoustic trauma. In Abstracts Joint Symposium, Cochlear Pharmacology and Noise Trauma: Prevention and Progress. London, 1998:9.
18. Narozny W, Sicko Z, Stankiewicz C, et al. Hyperbaric oxygen therapy in the treatment of some inner ear disorders [in Polish]. In Abstracts of the First International Symposium, Rehabilitation in Otology. Poznan, Poland: Scientific Society Better Hearing, 1999:111-4.
19. Probst R, Tschopp K, Ludin E, et al. A randomized, double-blind, placebo-controlled study of dextran-pentoxyfylline medication in acute acoustic trauma and sudden hearing loss. Acta Otolaryngol Stockh 1992;112:435-43.
20. Schwab B, Flunkert C, Heermann R, et al. HBO in the therapy of cochlear dysfunction: first results of a randomized study. In Proceedings of the 24th EUBS Congress. Stockholm, Sweden: European Underwater and Baromedical Society, 1998:40-2.
21. Appaix A, Pech A, Demara F. L'utilisation de l'oxygene hyperbare en otorhinolaryngologie. Ann Otolaryngol Chir Cervicofac 1970;87:735-50.
22. Lamm H. Klinische Ergebnisse nach Behandlung von Innenohrschwerhö rigkeiten mit hyperbaren Sauerstoff. Diskuss. Beitrag HNO-Jahreskongress der DDR, Halle, Germany, 1968.
23. Pilgramm M, Roth M, Fischer B. Der Einfluss der hyperbaren Oxygenation auf rheologische Parameter. Perfusion 1988;2:79-82.
24. Dauman R, Cross AM, Poisot D. Traitement des surditès brusques: premiers résultats d'une ètude comparative. J Otolaryngol 1985;14:49-56.
25. Pilgramm M, Lamm H, Schumann K. Zur hyperbaren Sauerstoff-therapie beim Hörsturz. Laryngol Rhinol Otol 19856;64:351-4.
26. Takahashi H, Sakakibara K, Murahashi K, et al. HBO for sudden deafness: a statistical survey over 907 ears. In Proceedings of the 2nd Swiss Symposium on Hyperbaric Medicine. Basel, Switzerland: Foundation for Hyperbaric Medicine, 1989.
27. Nakashima F, Fukuta S, Yanagita N. Hyperbaric oxygen therapy for sudden deafness. Adv Otorhinolaryngol 1998;54:100-9.
28. Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. Arch Otolaryngol 1980;106:772-6.
29. Wilkins SA, Mattox DE, Lyles A. Evaluation of "shotgun" regimen for sudden hearing loss. Otolaryngol Head Neck Surg 1987;97:471-80.
30. Weinaug P. Die Sponatauremission beim Hörsturz. HNO 1984;32:346-51.
31. Desloovere C, Meyer-Breiting E, Von Ilberg C. Randomisierte Doppelblindstudie zur Hörsturztherapie: Erste Ergebnisse. HNO 1988;36:417-22.
32. Pilgramm M, Schumann K. Hyperbaric oxygen therapy for acute acoustic trauma. Arch Otorhinolaryngol 1985;241:247-57.
33. Schumann K, Lamm K, Hetlich M. Zur Wirksamheit der hyperbaren Saurestofftherapie bei alten Hörstorungen: Bericht über 557 Fäle aus dem Jahre 1989. HNO 1990;38:408-11.
34. Guyton AC, Hall JE. Human Physiology and Mechanisms of Disease. 6th ed. Philadelphia: W.B. Saunders Co., 1997.
35. Cavallazzi GM. Relations between O2 and hearing function. In Proceedings of the 22nd EUBS Congress. Milano, Italy: European Underwater and Baromedical Society, 1996:633-45.
36. Almeling M, Welslau W, Bohm F, et al. HBO-treatment of negative selected patients with sudden deafness and tinnitus: a prospective multicenter study. In Proceedings of the 22nd EUBS Congress. Milano, Italy: European Underwater and Baromedical Society, 1996:651-6.
37. Pitovski KE, Dreschler MJ, Dreschler DG. High affinity aldosterone binding sites (type I receptors) in the mammalian inner ear. Hear Res 1993;69:10-4.
38. Rarey KE, Curtis LM, ten Cate WJF. Tissue specific level of glucocorticoid receptors within the rat inner ear. Hear Res 1993;64:205-10.
39. Rarey KE, Curtis LM. Receptors for glucocorticoids in the human inner ear. Otolaryngol Head Neck Surg 1996;115:38-41.
40. ten Cate WJF, Monder C, Marandici A, et al. 11 β-Hydroxysteroid dehydrogenase in rat inner ear. Am J Physiol 1994;266:260-73.
41. Baulieu EE, Mester J. Steroid hormone receptors. In DeGroot LJ, ed. Endocrinology. Philadelphia: W.B. Saunders Co., 1989:16-39.
42. Alberts B, Bray D, Johnson A, et al. Principles of Cell Biology: Introduction to Molecular Biology [in Polish]. Warsaw: PWN, 1999.
43. Iwasaki S, Mizuta K, Gao J, et al. Focal microcirculation disorders induced by photochemical reactions in guinea pig cochlea. Hear Res 1997;108:55-64.
44. Curtis LM, ten Cate WJF, Rarey KE. Dynamics of Na, K-ATPase sites in the lateral cochlear wall tissues of the rat. Eur Arch Otorhinolaryngol 1993;250:265-70.
45. Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed-up by clinical application. Laryngoscope 1999;109(Suppl):1-17.
46. Zuo J, Curtis L, Yao X, et al. Expression of Na, K-ATPase α- and β-isoforms in the neonatal rat cochlea. Acta Otolaryngol Stockh 1995;115:497-503.
47. Buhrer M, Frey FJ, Frey BM. Prednisolone concentrations in cerebrospinal fluid after different prednisolone prodrugs. Br J Pharmacol 1991;31:111-3.
48. Braughler JM, Hall ED, Means ED, et al. Evaluation of an intensive methylprednisolone sodium succinate dosing regimen in experimental spinal cord injury. J Neurosurg 1987;67:102-5.
49. Means ED, Anderson DK, Waters TR, et al. Effects of methyl-prednisolone in compression trauma of the feline spinal cord. J Neurosurg 1981;55:200-8.
50. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury: result of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990;322:1405-11.
51. Moskowitz D, Lee KJ, Smith HW. Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope 1984;94:664-6.
52. Veldman JE, Hanada T, Meeuwsen F. Diagnostic and therapeutic dilemmas in rapidly progressive sensorineural hearing loss and sudden deafness: a reappraisal of immune reactivity in inner ear disorders. Acta Otolaryngol Stockh 1993;113:303-6.
53. Cinamon U, Bendet E, Kronenberg J. Steroids, carbogen or placebo for sudden hearing loss: a prospective double-blind study. Eur Arch Otorhinolaryngol 2001;258:477-80.
54. Laurikainen EA, Miller JM, Nuttall AL, et al. The vascular mechanism of action of betahistine in the inner ear of the guinea pig. Eur Arch Otorhinolaryngol 1998;255:119-23.
55. Martinez DM. The effect of Sere (betahistine hydrochloride) on the circulation of the inner ear in experimental animals. Acta Otolaryngol Stockh 1972;305(Suppl):29-47.
56. Suga F, Snow JB. Cochlear blood flow in response to vasodilating drugs and some related agents. Laryngoscope 1969;79:1956-78.
57. Arrang JM, Garbarg M, Quach TT, et al. Actions of betahistine at histamine receptors in the brain. Eur J Pharmacol 1985;111:73-84.
58. Hultcrantz E, Nuttall A. Effect of hemodilution on cochlear blood flow measured by laser-Doppler flowmetry. Am J Otolaryngol 1987;8:16-22.
59. Nuttall A, Hultcrantz E, Larsen H, et al. Cochlear blood flow increases after systemic hemodilution: comparison of simultaneous laser Doppler flowmetry and radioactive microsphere measurements. Hear Res 1988;34:215-23.
60. Saeki N, Kitahara M. Assessment of prognosis in sudden deafness. Acta Otolaryngol Stockh 1994;510(Suppl):56-61.